Targeting CD47 as a novel immunotherapy for multiple myeloma

Authors

Jennifer Sun, Washington University School of Medicine in St. Louis
Barbara Muz, Washington University School of Medicine in St. Louis
Kinan Alhallak, Washington University School of Medicine in St. Louis
Matea Markovic, St. Louis College of Pharmacy
Shannon Gurley, Washington University School of Medicine in St. Louis
Zhe Wang, Washington University School of Medicine in St. Louis
Nicole Guenthner, Washington University School of Medicine in St. Louis
Katherine Wasden, Washington University School of Medicine in St. Louis
Mark Fiala, Washington University School of Medicine in St. Louis
Justin King, Washington University School of Medicine in St. Louis
Daniel Kohnen, Washington University School of Medicine in St. Louis
Noha Nabil Salama, St. Louis College of Pharmacy
Ravi Vij, Washington University School of Medicine in St. Louis
Abdel Kareem Azab, Washington University School of Medicine in St. Louis

Journal

Cancers (Basel)

Publication Date

2020

Volume

12

Issue

2

First Page

305

Document Type

Open Access Publication

DOI

10.3390/cancers12020305

Rights and Permissions

Sun J, Muz B, Alhallak K, Markovic M, Gurley S, Wang Z, Guenthner N, Wasden K, Fiala M, King J, Kohnen D, Salama NN, Vij R, Azab AK. Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma. Cancers. 2020; 12(2):305. doi: 10.3390/cancers12020305.

Recommended Citation

Sun, Jennifer; Muz, Barbara; Alhallak, Kinan; Markovic, Matea; Gurley, Shannon; Wang, Zhe; Guenthner, Nicole; Wasden, Katherine; Fiala, Mark; King, Justin; Kohnen, Daniel; Salama, Noha Nabil; Vij, Ravi; and Azab, Abdel Kareem, "Targeting CD47 as a novel immunotherapy for multiple myeloma." Cancers (Basel). 12, 2. 305 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/8795